HEADER ISOMERASE 06-JUL-09 3I6C TITLE STRUCTURE-BASED DESIGN OF NOVEL PIN1 INHIBITORS (II) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 45-163; COMPND 5 SYNONYM: ROTAMASE PIN1, PPIASE PIN1; COMPND 6 EC: 5.2.1.8; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PIN1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SBDD, SMALL MOLECULE, PPIASE, CELL CYCLE, ISOMERASE, NUCLEUS, KEYWDS 2 PHOSPHOPROTEIN, ROTAMASE EXPDTA X-RAY DIFFRACTION AUTHOR S.E.GREASLEY,R.A.FERRE REVDAT 3 21-FEB-24 3I6C 1 REMARK REVDAT 2 13-OCT-21 3I6C 1 REMARK SEQADV REVDAT 1 21-APR-10 3I6C 0 JRNL AUTH L.DONG,J.MARAKOVITS,X.HOU,C.GUO,S.GREASLEY,E.DAGOSTINO, JRNL AUTH 2 R.FERRE,M.C.JOHNSON,E.KRAYNOV,J.THOMSON,V.PATHAK,B.W.MURRAY JRNL TITL STRUCTURE-BASED DESIGN OF NOVEL HUMAN PIN1 INHIBITORS (II). JRNL REF BIOORG.MED.CHEM.LETT. V. 20 2210 2010 JRNL REFN ISSN 0960-894X JRNL PMID 20207139 JRNL DOI 10.1016/J.BMCL.2010.02.033 REMARK 2 REMARK 2 RESOLUTION. 1.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.164 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2634 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 50063 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.153 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.200 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 2208 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 42647 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1756 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 166 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 1999.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 4 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 18012 REMARK 3 NUMBER OF RESTRAINTS : 22438 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 ANGLE DISTANCES (A) : 0.029 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.031 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.057 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.071 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.019 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.004 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.040 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.088 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3I6C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JUL-09. REMARK 100 THE DEPOSITION ID IS D_1000054019. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JAN-02 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52797 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.300 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.46800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIFFERENCE FOURIER REMARK 200 SOFTWARE USED: ARP/WARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.24 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM SULFATE, 0.9M NA REMARK 280 CITRATE, 5MM TCEP, 100MM HEPES, PH 8.0, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 286K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 58.98350 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 18.32400 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 58.98350 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 18.32400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 41 REMARK 465 SER A 42 REMARK 465 HIS A 43 REMARK 465 MET A 44 REMARK 465 GLY A 45 REMARK 465 LYS A 46 REMARK 465 ASN A 47 REMARK 465 GLY A 48 REMARK 465 GLN A 49 REMARK 465 GLY A 50 REMARK 465 GLY B 41 REMARK 465 SER B 42 REMARK 465 HIS B 43 REMARK 465 MET B 44 REMARK 465 GLY B 45 REMARK 465 LYS B 46 REMARK 465 ASN B 47 REMARK 465 GLY B 48 REMARK 465 GLN B 49 REMARK 465 GLY B 50 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 68 NE CZ NH1 NH2 REMARK 470 ARG A 69 NE CZ NH1 NH2 REMARK 470 ARG A 142 NE CZ NH1 NH2 REMARK 470 GLU B 76 CD OE1 OE2 REMARK 470 GLN B 94 CG CD OE1 NE2 REMARK 470 GLN B 131 CG CD OE1 NE2 REMARK 470 LYS B 132 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU B 51 CD GLU B 51 OE2 0.066 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE A 103 CB - CG - CD1 ANGL. DEV. = 6.3 DEGREES REMARK 500 PHE B 103 CB - CG - CD2 ANGL. DEV. = -4.4 DEGREES REMARK 500 PHE B 103 CB - CG - CD1 ANGL. DEV. = 5.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 GIA A 301 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GIA A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GIA A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GIA B 302 DBREF 3I6C A 45 163 UNP Q13526 PIN1_HUMAN 45 163 DBREF 3I6C B 45 163 UNP Q13526 PIN1_HUMAN 45 163 SEQADV 3I6C GLY A 41 UNP Q13526 EXPRESSION TAG SEQADV 3I6C SER A 42 UNP Q13526 EXPRESSION TAG SEQADV 3I6C HIS A 43 UNP Q13526 EXPRESSION TAG SEQADV 3I6C MET A 44 UNP Q13526 EXPRESSION TAG SEQADV 3I6C GLN A 77 UNP Q13526 LYS 77 ENGINEERED MUTATION SEQADV 3I6C GLN A 82 UNP Q13526 LYS 82 ENGINEERED MUTATION SEQADV 3I6C GLY B 41 UNP Q13526 EXPRESSION TAG SEQADV 3I6C SER B 42 UNP Q13526 EXPRESSION TAG SEQADV 3I6C HIS B 43 UNP Q13526 EXPRESSION TAG SEQADV 3I6C MET B 44 UNP Q13526 EXPRESSION TAG SEQADV 3I6C GLN B 77 UNP Q13526 LYS 77 ENGINEERED MUTATION SEQADV 3I6C GLN B 82 UNP Q13526 LYS 82 ENGINEERED MUTATION SEQRES 1 A 123 GLY SER HIS MET GLY LYS ASN GLY GLN GLY GLU PRO ALA SEQRES 2 A 123 ARG VAL ARG CYS SER HIS LEU LEU VAL LYS HIS SER GLN SEQRES 3 A 123 SER ARG ARG PRO SER SER TRP ARG GLN GLU GLN ILE THR SEQRES 4 A 123 ARG THR GLN GLU GLU ALA LEU GLU LEU ILE ASN GLY TYR SEQRES 5 A 123 ILE GLN LYS ILE LYS SER GLY GLU GLU ASP PHE GLU SER SEQRES 6 A 123 LEU ALA SER GLN PHE SER ASP CYS SER SER ALA LYS ALA SEQRES 7 A 123 ARG GLY ASP LEU GLY ALA PHE SER ARG GLY GLN MET GLN SEQRES 8 A 123 LYS PRO PHE GLU ASP ALA SER PHE ALA LEU ARG THR GLY SEQRES 9 A 123 GLU MET SER GLY PRO VAL PHE THR ASP SER GLY ILE HIS SEQRES 10 A 123 ILE ILE LEU ARG THR GLU SEQRES 1 B 123 GLY SER HIS MET GLY LYS ASN GLY GLN GLY GLU PRO ALA SEQRES 2 B 123 ARG VAL ARG CYS SER HIS LEU LEU VAL LYS HIS SER GLN SEQRES 3 B 123 SER ARG ARG PRO SER SER TRP ARG GLN GLU GLN ILE THR SEQRES 4 B 123 ARG THR GLN GLU GLU ALA LEU GLU LEU ILE ASN GLY TYR SEQRES 5 B 123 ILE GLN LYS ILE LYS SER GLY GLU GLU ASP PHE GLU SER SEQRES 6 B 123 LEU ALA SER GLN PHE SER ASP CYS SER SER ALA LYS ALA SEQRES 7 B 123 ARG GLY ASP LEU GLY ALA PHE SER ARG GLY GLN MET GLN SEQRES 8 B 123 LYS PRO PHE GLU ASP ALA SER PHE ALA LEU ARG THR GLY SEQRES 9 B 123 GLU MET SER GLY PRO VAL PHE THR ASP SER GLY ILE HIS SEQRES 10 B 123 ILE ILE LEU ARG THR GLU HET GIA A 301 8 HET GIA A 303 25 HET GIA B 302 25 HETNAM GIA 3-FLUORO-N-(NAPHTHALEN-2-YLCARBONYL)-D-PHENYLALANINE FORMUL 3 GIA 3(C20 H16 F N O3) FORMUL 6 HOH *166(H2 O) HELIX 1 1 THR A 81 GLY A 99 1 19 HELIX 2 2 ASP A 102 SER A 111 1 10 HELIX 3 3 CYS A 113 ARG A 119 5 7 HELIX 4 4 GLN A 131 LEU A 141 1 11 HELIX 5 5 THR B 81 SER B 98 1 18 HELIX 6 6 ASP B 102 SER B 111 1 10 HELIX 7 7 CYS B 113 ARG B 119 5 7 HELIX 8 8 GLN B 131 ALA B 140 1 10 SHEET 1 A 4 ASP A 121 SER A 126 0 SHEET 2 A 4 ARG A 54 VAL A 62 -1 N CYS A 57 O LEU A 122 SHEET 3 A 4 GLY A 155 GLU A 163 -1 O ILE A 156 N VAL A 62 SHEET 4 A 4 VAL A 150 THR A 152 -1 N VAL A 150 O HIS A 157 SHEET 1 B 4 ASP B 121 PHE B 125 0 SHEET 2 B 4 VAL B 55 VAL B 62 -1 N VAL B 55 O PHE B 125 SHEET 3 B 4 GLY B 155 GLU B 163 -1 O ILE B 156 N VAL B 62 SHEET 4 B 4 VAL B 150 THR B 152 -1 N VAL B 150 O HIS B 157 SITE 1 AC1 5 HIS A 59 GLN A 131 PHE A 134 SER A 154 SITE 2 AC1 5 HIS A 157 SITE 1 AC2 11 HOH A 38 ARG A 74 GLN A 75 ARG A 80 SITE 2 AC2 11 LEU A 88 PHE A 110 HOH A 168 GLN B 82 SITE 3 AC2 11 GLU B 83 LEU B 86 PHE B 151 SITE 1 AC3 11 HIS B 59 LEU B 61 LYS B 63 ARG B 68 SITE 2 AC3 11 CYS B 113 SER B 114 LEU B 122 PHE B 134 SITE 3 AC3 11 SER B 154 HOH B 171 HOH B 199 CRYST1 117.967 36.648 51.293 90.00 100.99 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008477 0.000000 0.001646 0.00000 SCALE2 0.000000 0.027287 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019860 0.00000